Novartis raises drug sales forecast, plans new stock buybacks
Bio Pharma Dive
JULY 18, 2023
The pharma company, which will soon split off its generic drug unit, plans to repurchase up to $15 billion of its shares through the end of 2025.
130 
Inflation threatens supply of life-saving generics to Europe
Pharmaceutical Technology
DECEMBER 15, 2022
Inflation at its current levels poses a major threat to generics production and usage. Since the summer, generics makers have been signalling that additional support for help with rising costs is required to keep generics production viable. Inflation can damage production viability of European drugs.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Disruption in healthcare is coming
World of DTC Marketing
JUNE 22, 2022
PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. Then there is the cost of generic drugs. billion in 2020 if it had purchased 77 of 89 drugs from Cuban’s firm.
Should we be worried about pharma’s supply chain?
World of DTC Marketing
APRIL 12, 2021
Ironically, in later times, the intense competition for out-of-patent drugs has subsided, which has led to spiraling rises in generic drug prices and shortages. Most of these generics are produced outside the US and recently there have been numerous recalls of generic drugs because of the failure of quality control.
PBMs and insurers want your prescription money
World of DTC Marketing
JULY 27, 2022
Huge Insurance companies continue shifting costs onto patients, with disastrous consequences for individuals’ health and society. Pharma companies have very little control over patients’ prices for their Rxs. Insurers have started coming after the co-pay coupons that many drug companies issue directly to patients.
In the News: October Regulatory and Development Updates
Camargo
NOVEMBER 11, 2020
In November 2017, Foundation Medicine received approval for FoundationOne CDx , a genomic profiling test for solid state tumors, which paved the way for partnerships with pharma companies’ therapeutics. The generic drug must also have the same labeling as the RLD (except for differences permitted under the Agency regulations).
Common sense approach to the pharma industry
World of DTC Marketing
DECEMBER 18, 2020
Pharma companies are still too focused on profits while people continue to rely on prescription drugs to compensate for unhealthy lifestyles. The headline and byline in a Times editorial said it all “Don’t Fall for Big Pharma’s Savior Act, Heroic work went into the development of the coronavirus vaccines.
Let's personalize your content